Precision BioSciences to Present In Vivo Gene Therapy and Ex Vivo Cancer Immunotherapy Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

DURHAM, North Carolina, USA, May 14 2018 – Precision BioSciences, the ARCUS genome editing company with novel product development programs in gene therapy, cancer immunotherapy and non-GMO food,...


Cargill announces ongoing partnership with Precision BioSciences enabling healthy canola oil products

Durham, NC Feb. 22, 2018 – Cargill today announced an ongoing partnership with Precision BioSciences to advance its program in healthy canola oils with the lowest saturate levels on the market...


Precision CEO Matt Kane Discusses the Unique Features of ARCUS with PMWC

  On January 22nd 2018, Precision BioSciences CEO and Co-founder Matt Kane will participate in the Silicon Valley Precision Medicine World Conference (PMWC), sharing his insights as part of...


Precision PlantSciences Helps Establish Vision and Goals for Crops of the Future Collaborative

DURHAM, North Carolina, USA, September 19 2017 – President of Precision PlantSciences, Fayaz Khazi, Ph.D., joined the other founding partners of the Crops of the Future (COTF) collaborative in...


David Thomson Joins Precision BioSciences as Chief Development Officer

DURHAM, North Carolina, USA, July 10 2017 – Precision BioSciences is pleased to welcome David Thomson, Ph.D., into a newly created position of Chief Development Officer. At Precision, David will...


Precision PlantSciences partners with Bayer, BioGemma, KWS, FAPESP, Rijk Zwaan and CIMMYT through the FFAR Crops of the Future Collaborative

DURHAM, North Carolina, USA, June 29, 2017 – Precision PlantSciences has signed on to a new initiative supported by the 2014 Farm Bill and run through the non-profit organization the Foundation...


Precision BioSciences Welcomes Fayaz Khazi, Ph.D. as President of PlantSciences

DURHAM, North Carolina, USA, June 16, 2017 – Precision BioSciences has appointed Fayaz Khazi, Ph.D., to serve as the President of Precision PlantSciences, a business unit developing innovative,...


Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology

BANNOCKBURN, Ill. and DURHAM, North Carolina, February 25, 2016 – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients...